Aquestive Therapeutics
AQST
AQST
121 hedge funds and large institutions have $131M invested in Aquestive Therapeutics in 2025 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 46 increasing their positions, 29 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.82% less ownership
Funds ownership: 47.57% → 44.76% (-2.8%)
15% less capital invested
Capital invested by funds: $154M → $131M (-$23.6M)
58% less call options, than puts
Call options by funds: $391K | Put options by funds: $923K
Holders
121
Holding in Top 10
3
Calls
$391K
Puts
$923K
Top Buyers
| 1 | +$10.8M | |
| 2 | +$2.35M | |
| 3 | +$2.29M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.86M |
| 5 |
Two Sigma Advisers
New York
|
+$1.63M |
Top Sellers
| 1 | -$9.36M | |
| 2 | -$7.6M | |
| 3 | -$5.74M | |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$2.22M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$792K |
